APL Healthcare Limited — Prednisone Exporter Profile
Indian Pharmaceutical Exporter · #5 for Prednisone · $1.2M export value · DGFT Verified
APL Healthcare Limited is the #5 Indian exporter of Prednisone with $1.2M in export value and 32 verified shipments. APL Healthcare Limited holds a 4.5% market share in Prednisone exports across 2 countries. The company exports 17 pharmaceutical products worth $27.3M across 11 therapeutic categories.
APL Healthcare Limited — Prednisone Export Profile: Buyers & Destinations
Where Does APL Healthcare Limited Export Prednisone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $443.7K | 13 | 42.9% |
| UNITED STATES OF AMERICA | $325.5K | 10 | 31.5% |
| MALTA | $265.0K | 9 | 25.6% |
APL Healthcare Limited exports Prednisone to 3 countries. The largest destination is UNITED STATES accounting for 42.9% of APL Healthcare Limited's Prednisone shipments, followed by UNITED STATES OF AMERICA (31.5%) and MALTA (25.6%). These destinations reflect APL Healthcare Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Prednisone from APL Healthcare Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROBINDO PHARMA USA INC | UNITED STATES | $443.7K | 13 |
| XXROBXXDO XXARMXXUSAXX INXX | UNITED STATES OF AMERICA | $325.5K | 10 |
| XXL SXXFT XXRVIXXS (XXLTAXXLIMITEDXX | MALTA | $145.4K | 4 |
| APL SWIFT SERVICES MALTA LIMITED | MALTA | $95.2K | 3 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $24.4K | 2 |
APL Healthcare Limited supplies Prednisone to 5 buyers globally. The largest buyer is AUROBINDO PHARMA USA INC (UNITED STATES), followed by XXROBXXDO XXARMXXUSAXX INXX (UNITED STATES OF AMERICA) and XXL SXXFT XXRVIXXS (XXLTAXXLIMITEDXX (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Prednisone Export Value and How Much Does APL Healthcare Limited Contribute?
India exported $21.2M worth of Prednisone through 973 shipments from 46 suppliers to 45 countries, serving 196 buyers globally. APL Healthcare Limited contributes $1.2M to this total, accounting for 4.5% of India's Prednisone exports. APL Healthcare Limited ships Prednisone to 3 countries through 5 buyers.
What Is the Average Shipment Value for APL Healthcare Limited's Prednisone Exports?
APL Healthcare Limited's average Prednisone shipment value is $39.0K per consignment, based on 32 shipments totaling $1.2M. The largest destination is UNITED STATES (42.9% of APL Healthcare Limited's Prednisone exports).
How Does APL Healthcare Limited Compare to Other Indian Prednisone Exporters?
APL Healthcare Limited ranks #5 among 46 Indian Prednisone exporters with a 4.5% market share. The top 3 exporters are STRIDES PHARMA SCIENCE LIMITED ($10.1M), PAR FORMULATIONS PRIVATE LIMITED ($4.7M), WATSON PHARMA PRIVATE LIMITED ($3.0M). APL Healthcare Limited processed 32 shipments to 2 destination countries.
What Prednisone Formulations Does APL Healthcare Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PREDNISONE TABLETS USP 50 MG | $387.0K | 11 |
| PREDNISONE TABLETS USP 1 MG | $305.5K | 9 |
| PREDNISONE TABLETS USP 20 MG | $146.4K | 5 |
| PREDNISONE TABLETS 5 MG | $94.2K | 2 |
| PREDNISONE TABLETS USP 5 MG | $74.4K | 3 |
| PREDNISONE TABLETS USP 50 MG 100'S PACK | $26.7K | 2 |
APL Healthcare Limited exports 6 distinct Prednisone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PREDNISONE TABLETS USP 50 MG with 11 shipments worth $387.0K.
Regulatory Requirements: Exporting Prednisone to Key Markets
What APL Healthcare Limited must comply with to export Prednisone to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does APL Healthcare Limited Compare to Nearest Prednisone Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | WATSON PHARMA PRIVATE LIMITED | $3.0M | 60 | 1 | $50.0K |
| 4 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $1.4M | 27 | 1 | $50.0K |
| 5 | APL HEALTHCARE LIMITED ★ | $1.2M | 32 | 2 | $39.0K |
| 6 | WATSON PHARMA PVT LTD | $200.0K | 4 | 1 | $50.0K |
| 7 | ZYREX HEALTHCARE PRIVATE LIMITED | $188.5K | 4 | 1 | $47.1K |
APL Healthcare Limited ranks #5 among 46 Indian Prednisone exporters. Average shipment value of $39.0K compared to the market average of $460.0K. The closest competitors by value are WATSON PHARMA PRIVATE LIMITED and AMNEAL PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Prednisone Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 185 | 19.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 156 | 16.0% |
| CHENNAI AIR CARGO ACC (INMAA4) | 97 | 10.0% |
| BANGALORE ICD | 91 | 9.4% |
| BANGALORE ICD (INWFD6) | 52 | 5.3% |
| NHAVA SHEVA SEA (INNSA1) | 39 | 4.0% |
| KAMARAJAR PORT (INENR1) | 35 | 3.6% |
| Bombay Air | 35 | 3.6% |
Geopolitical & Trade Policy Impact on APL Healthcare Limited's Prednisone Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like APL Healthcare. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and inventory management. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative pharmaceutical suppliers, potentially benefiting Indian exporters. However, the looming threat of US tariffs on pharmaceutical imports adds a layer of uncertainty. In March 2025, Indian pharma exports to the US surged by 74% amid tariff concerns, indicating proactive measures by exporters to mitigate potential impacts. (business-standard.com)
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. This development offers APL Healthcare an opportunity to strengthen its presence in the European market, provided it aligns with EU regulatory standards. (en.wikipedia.org)
APL Healthcare Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. India has made significant strides in this area, with 752 FDA-approved, 2,050 WHO GMP-certified, and 286 EDQM-approved manufacturing sites as of 2024. (business-standard.com) This robust compliance framework enhances the credibility of Indian pharmaceuticals in global markets.
For APL Healthcare, maintaining and enhancing compliance with FDA, WHO, and EU GMP standards is crucial. Adherence to evolving quality requirements not only ensures market access but also builds trust with international partners. Continuous investment in quality assurance and regulatory affairs will be essential to navigate the complex global pharmaceutical landscape.
About APL Healthcare Limited
APL Healthcare Limited exports 17 products worth $27.3M. Beyond Prednisone, top products include Sertraline, Potassium, Fluoxetine, Tenofovir, Dolutegravir. View the complete APL Healthcare Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Prednisone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Prednisone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: APL Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching APL Healthcare Limited exporting Prednisone, covering 6 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 45+ countries, 196+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Prednisone Export Data from APL Healthcare Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for APL Healthcare Limited's Prednisone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APL Healthcare Limited
Full Company Profile →
17 products · $27.3M total trade · 11 categories
Prednisone Stats
Company Overview
Top Products by APL Healthcare Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for APL Healthcare Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Prednisone. For current shipment-level data, contact TransData Nexus.